Two cases of osteosarcoma occurring as second malignancy of childhood cancer

Anticancer Research

Volumn 19, Issue 6 C, 1999, Pages 5563-5565

  Yonemoto, Tsukasa ^a   Tatezaki, Shin Ichiro ^a   Ishii, Takeshi ^a   Satoh, Tetsuzo ^a   Inoue, Masatoshi ^b  

^a CHIBA CANCER CENTER   (Japan)

^b Chiba Higashi Hospital   (Japan)

Author keywords

Chemotherapy; Childhood cancer; Osteosarcoma; p53 tumor suppressor gene; Second malignancy

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE; PROTEIN P53;

ADOLESCENT; ADRENAL CORTEX CARCINOMA; ARTICLE; CASE REPORT; CHILDHOOD CANCER; FEMALE; GENE MUTATION; HUMAN; MALIGNANT TERATOMA; OSTEOSARCOMA; PRIORITY JOURNAL; SCHOOL CHILD; SECOND CANCER; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; BUTTOCKS; CHILD; FEMALE; FEMUR; HUMANS; NEOPLASMS, SECOND PRIMARY; OSTEOSARCOMA; TERATOMA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033368087     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Meadows AT, Strong LC, Li FP et al: Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition. Cancer 46: 2603-2606, 1980.
2. Meadows AT, Baum E, Fossati-Bellani F et al: Second malignant neoplasms in children. An update from the late effects study group. J Clin Oncol 3: 532-538, 1985.
3. Tucker MA, D'Angio GJ, Boice Jr JD et al: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317: 588-593, 1987.
4. Dickman PS, Barmada M, Gollin SM, Blatt J: Malignancy after retinoblastoma. Secondary cancer or recurrence? Hum Pathol 28: 200-205, 1997.
5. Draper GJ, Sanders BM, Kingston JE: Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53: 661-671, 1986.
6. Li FP, Fraumeni JF: Rhabdomyosarcoma in children, epidemiology study and identification of a familial cancer syndrome. J Natl Cancer Inst 43: 1365-1373, 1969.
7. Pratt CB, Meyer WH, Rao BN et al: Comparison of primary osteosarcoma of flat hones with secondary ostesarcoma of any site. Cancer 80: 1171-1177, 1997.
8. Malkin D, Li FP, Strong LC et al: Germ line p53 mutations in a familial syndrome of sarcomas, breast cancer and other neoplasms. Science 250: 1233-1238, 1990.
9. Benjamin RS, Legra SS, Patel SR, Nicaise C: Single-agent ifosfamide studies in sarcomas of soft tissue and bone. The M.D. Anderson experience. Cancer chemother Pharmacol 31: 174-179, 1943.
10. Saleh RA, Graham-Pole J, Cassano W et al: Response of osteogenic sarcoma to the combination of etoposide and cyclophosphamide as neoadjuvant chemotherapy. Cancer 65: 861-865, 1990.